JAWAHARLAL NEHRU TECHNOLOGICAL UNIVERSITY HYDERABAD Pharm.D(Post Baccalaureate) II Year CLINICAL PHARMACOKINETICS AND PHARMACOTHERAPEUTIC DRUG MONITORING Previous Question Paper (Oct/Nov - 2019 - R08)

Clinical pharmacokinetics is the application of pharmacokinetic principles to the safe and effective therapeutic management of individual patients. It involves the study of the time course of drug absorption, distribution, metabolism, and excretion to optimize drug dosing regimens.

Its primary applications include:

• Designing individualized dosage regimens based on patient-specific parameters like age, weight, and organ function.
• Monitoring drug concentrations in plasma to ensure levels remain within the therapeutic window.
• Adjusting doses for patients with renal or hepatic impairment to prevent toxicity or sub-therapeutic effects.
• Evaluating drug-drug interactions that may alter the pharmacokinetic profile of a medication.
• Interpreting pharmacokinetic data to guide clinical decision-making in complex patient cases.

The frequency of drug administration is determined primarily by the drug's half-life (t_1/2) and the required therapeutic range. The goal is to maintain plasma concentrations between the minimum effective concentration (MEC) and the minimum toxic concentration (MTC).

The steps to determine the dosing interval (τ) are:

1. Identify the desired steady-state concentration (Css) based on the therapeutic range.
2. Calculate the elimination rate constant (k) using the formula:
   k = 0.693 / t_1/2
3. Determine the accumulation factor to assess how much drug remains in the body from previous doses.
4. Calculate the dosing interval (τ) using the relationship between the peak and trough concentrations:
   τ = ln(C_max,ss / C_min,ss) / k
5. Adjust the interval to standard clinical time frames (e.g., every 8, 12, or 24 hours) to ensure patient compliance while keeping fluctuations within the therapeutic window.